Monte Rosa Therapeutics GLUE
NASDAQ GLUE
$10.50 -0.76 (-6.75%)
At close: Oct 2, 2026 · 4:00 PM EDT

Monte Rosa Therapeutics (GLUE) Price to FCF (2024 - 2025)

Updated

Monte Rosa Therapeutics' (GLUE) Price to FCF came in at 4.21 for Q3 2025, down 72.9% from the prior quarter.

Analysis

Monte Rosa Therapeutics (GLUE) Price to FCF (2024 - 2025) Analysis & Trends

For FY2024, Monte Rosa Therapeutics' Price to FCF stood at 11.23.

  • According to Business Quant data, Price to FCF for the three prior quarters was 15.54 (Q2 2025), 12.51 (Q1 2025) and 11.23 (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Monte Rosa Therapeutics 894.88 Mn 306.69 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 4.21
Jun 30, 2025 15.54
Mar 31, 2025 12.51
Dec 31, 2024 11.23
API Access

Monte Rosa Therapeutics Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=GLUE&period=max&api_key=YOUR_API_KEY